Mr. Gotfredson serves as Member of Board of Directors and CFO for Neuropore Therapies Inc. He graduated in accounting from the University of San Diego in 1989. He has 20 years of experience working with small to mid-size life science and hi-tech companies in San Diego. For the last 5 years, his practice has focused on biotechnology corporate administration, accounting system reviews and implementations, financial reporting, planning, budgeting, forecasting and cost control. He has also served as CFO for Biomatrica and Olympus Communications Technology of America.
A Pre-Clinical Study in a PD-like Transgenic Pre-Clinical Model of a Novel Isoindole Compound that Selectively Blocks Alpha-Synuclein Oligomerization